Analysis finds schizophrenics have thinner cerebral cortex, on average

June 6, 2018 by Latina Emerson, Georgia State University
Credit: Georgia State University

Individuals with schizophrenia, on average, have a thinner cerebral cortex, the largest part of the brain that controls higher intellectual functions and motor activity, compared to healthy people, according to an international study co-led by Georgia State University and the University of California, Irvine.

Schizophrenia is a severe mental disorder that affects how a person thinks, feels and behaves. It is one of the top 15 leading causes of disability worldwide, and symptoms include psychotic symptoms, such as hallucinations, delusions and unusual ways of thinking, as well as reduced expression of emotions, difficulty in social relationships and cognitive impairment. The mental disorder is typically diagnosed in the late teens to early 30s and tends to emerge earlier in males. Because the causes of are still unknown, treatments focus on eliminating the symptoms of the disease, according to the National Institute of Mental Health.

The study, the largest meta-analysis of and surface area differences in schizophrenia, was conducted by the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Schizophrenia Working Group, a collaboration of schizophrenia researchers from all over the world. Brain abnormalities are widely reported in schizophrenia, but studies can disagree in their findings. The meta-analysis – a statistical procedure for combining data across multiple studies – uses the data already collected from these studies to identify more powerfully how irregularities in cortical thickness and surface area are related to schizophrenia.

The international research team analyzed data from 9,572 participants, including 4,474 individuals with schizophrenia and 5,098 healthy volunteers. The study combined data samples from 39 centers worldwide, which already had neuroimaging data on individuals with and without schizophrenia. Each site processed structural scans for their study participants using the same methods and statistics, and researchers submitted the results to the ENIGMA Schizophrenia Working Group to be evaluated as part of the larger meta-analysis.

"This is the largest meta-analysis on cortical brain effects in individuals with schizophrenia ever published, and this is the largest collaborative group working on this topic," said Dr. Jessica Turner, senior author of the study and associate professor of psychology and neuroscience at Georgia State. "Our main take-home finding is we are seeing brain regions that are thinner in the schizophrenia group pretty much everywhere in the brain, with the largest effect sizes being in the inferior and superior temporal cortex. Interestingly, even with so many data points and the ability to find very small differences between the groups, the areas around the visual cortex, pericalcarine cortex, were not affected."

In this study, the researchers found the largest differences between schizophrenic and non-psychotic individuals in the frontal and temporal lobe regions of the brain. The frontal lobe plays vital roles in memory, attention, imagination, motivation and other daily tasks, and the temporal lobe includes areas involved in hearing, language, naming and memory, among others.

They also found cortical thickness in several regions was significantly associated with greater severity of schizophrenia symptoms, an earlier age of onset of schizophrenia or longer duration of illness. Compared to controls, individuals who were on first- or second-generation antipsychotic medications generally showed a thinner cortical thickness than individuals who were unmedicated. However, the researchers note this finding should not be used as a reason to withhold these drugs in treating severe mental illness, including schizophrenia, because they are the most effective treatments. The result, they said, should be used as a motivation to examine why that correlation exists. The findings are published in the journal Biological Psychiatry.

The researchers report that the major strength of this study is its large sample size, which provides sufficient power to detect even small effects. This group has already published the largest studies of subcortical volumes in schizophrenia, as well as white matter tracts, and meta-analyses of the relationship of cortical volume and symptom severity (Kelly et al., 2017; van Erp et al., 2016; Walton et al., 2017; Walton et al., 2018). The is also examining more subtle symptom questions, the role of family or early childhood events and other brain measures, and it is collaborating with other ENIGMA working groups focused on major depression and bipolar disorder.

Explore further: Brain connections in schizophrenia

More information: Theo GM. van Erp et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 controls via the ENIGMA consortium, Biological Psychiatry (2018). DOI: 10.1016/j.biopsych.2018.04.023

S Kelly et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group, Molecular Psychiatry (2017). DOI: 10.1038/mp.2017.170

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium, Molecular Psychiatry (2015). DOI: 10.1038/mp.2015.63

E. Walton et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium, Acta Psychiatrica Scandinavica (2017). DOI: 10.1111/acps.12718

E. Walton et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium, Psychological Medicine (2017). DOI: 10.1017/S0033291717001283

Related Stories

Brain connections in schizophrenia

March 9, 2018
Executive cognitive functions—abilities that include working memory and underlie mental control and self-regulation—are impaired in schizophrenia. Current pharmacological and behavioral interventions have only modest ...

Study identifies brain abnormalities in people with schizophrenia

July 7, 2015
Structural brain abnormalities in patients with schizophrenia, providing insight into how the condition may develop and respond to treatment, have been identified in an internationally collaborative study led by a Georgia ...

Schizophrenia affects your body, not just your brain – new study

May 11, 2018
Schizophrenia is considered a disorder of the mind, influencing the way a person thinks, feels and behaves. But our latest research shows that organs, other than the brain, also change at the onset of the disease.

Cerebellum plays a major role in schizophrenia

June 22, 2017
In a new study, Norwegian researchers have documented that the cerebellum is among the most affected brain regions in schizophrenia. Compared to healthy individuals, cerebellar volume was smaller in patients with schizophrenia. ...

Schizophrenia study identifies shifts in patterns of glutamate and GABA in visuospatial working memory network

January 18, 2018
A new study in Biological Psychiatry has characterized the patterns of brain neurotransmitters glutamate and GABA in a network of regions that temporarily maintain and process visual information about the location of objects ...

Schizophrenia a side effect of human development

February 21, 2018
Schizophrenia may have evolved as an "unwanted side effect" of the development of the complex human brain, a new study has found.

Recommended for you

Psychiatric disorders share an underlying genetic basis

June 21, 2018
Psychiatric disorders such as schizophrenia and bipolar disorder often run in families. In a new international collaboration, researchers explored the genetic connections between these and other disorders of the brain at ...

One year of school comes with an IQ bump, meta-analysis shows

June 21, 2018
A year of schooling leaves students with new knowledge, and it also equates with a small but noticeable increase to students' IQ, according to a systematic meta-analysis published in Psychological Science, a journal of the ...

Ketamine acts fast to treat depression and its effects last—but how?

June 21, 2018
In contrast to most antidepressant medications, which can take several weeks to reduce depressive symptoms, ketamine—a commonly used veterinary anesthetic—can lift a person out of a deep depression within minutes of its ...

Mindful movement may help lower stress, anxiety

June 21, 2018
Taking a walk may be a good opportunity to mentally review your to-do list, but using the time to instead be more mindful of your breathing and surroundings may help boost your wellbeing, according to researchers.

New study debunks Dale Carnegie advice to 'put yourself in their shoes'

June 21, 2018
Putting yourself in someone else's shoes and relying on intuition or "gut instinct" isn't an accurate way to determine what they're thinking or feeling," say researchers from Ben-Gurion University of the Negev (BGU), the ...

Brain tingles—first study of its kind reveals physiological benefits of ASMR

June 21, 2018
Autonomous sensory meridian response (ASMR) – the relaxing 'brain tingles' experienced by some people in response to specific triggers, such as whispering, tapping and slow hand movements – may have benefits for both ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.